Forskningsradar
← Alla bevakningsområden

Life Sciences

1711 artiklar · sida 58 av 69

🇸🇪 Endast svenska
4.0

Researchers have identified leptin, a hormone released by fat tissue, as a potential biomarker for cardiovascular risk—offering a new target for both weight loss treatments and heart disease prevention. The finding could reshape how doctors assess cardiac risk in obese patients and drive development of leptin-targeting therapies worth billions in pharmaceutical markets.EN

2023-01-01 ·
4.0

Researchers used deep learning to extract more genetic insights from existing psychiatric studies, tripling the number of disease-linked genetic variants detected without collecting new patient samples. The breakthrough could accelerate drug development by revealing overlooked therapeutic targets while sidestepping the prohibitive cost of enrolling hundreds of thousands of additional study participants.EN

2023-01-01 · RES SQ · , , et al.
4.0

Researchers discovered that the muscles controlling sound in the human ear contain muscle fibers unlike any others in the body—dominated by fast-twitch fibers and expressing protein variants never seen before. The findings could unlock new approaches to hearing disorders and have implications for understanding how the body fine-tunes precise, rapid movements.EN

2023-01-01 · Journal of Anatomy · , , et al.
4.0

A new study finds that older adults follow a robot's head movements to locate targets on screen just as readily as younger people do—challenging assumptions about age-related cognitive decline. The finding has immediate implications for designing robotic assistants in healthcare and eldercare settings, where directing attention and cooperation is essential.EN

2023-01-01 · Cognitive Systems Research · , ,
4.0

A vaccine protecting elms from a devastating fungal disease also reduces lichens and certain fungi living on treated trees, a new study finds. The discovery complicates conservation efforts: while the vaccine saves iconic trees, it may reshape the microbial ecosystems that depend on them, forcing forestry managers to weigh ecological tradeoffs.EN

2023-01-01 · Journal of Fungi · , ,
4.0

Researchers discovered that robots can direct where people look simply by turning their heads—even when their eyes are invisible. The finding reveals that humans instinctively treat robotic head movements as intentional social signals, opening new possibilities for how autonomous systems could guide worker attention, influence customer behavior, or assist people with disabilities.EN

2023-01-01 · HRI '23: Companion of the 2023 ACM/IEEE International Conference on Human-Robot Interaction · , , et al.
4.0

Researchers mapping how chromosomes physically organize in 3D space found the classic hierarchical model was wrong. The finding could reshape drug development and genetic therapies by revealing how cells actually control which genes turn on and off.EN

2023-01-01 · PloS Computational Biology · , , et al.
4.0

Researchers have developed mathematical models that successfully integrate three major types of cellular data — DNA accessibility, gene activity, and protein levels — opening a path to faster disease diagnosis and drug development. The breakthrough addresses a critical bottleneck: labs can now generate vast amounts of multi-layered biological data, but lack the tools to make sense of it together.EN

2023-01-01 ·
4.0

Researchers have identified how a common inflammatory response paradoxically makes heart disease worse by releasing a protein that prevents the liver from clearing harmful LDL cholesterol. The finding could reshape how doctors think about treating cardiovascular disease in patients with chronic inflammation, potentially opening new drug targets.EN

2023-01-01 · Journal of Molecular Medicine · , , et al.
4.0

A new review exposes a major gap in our understanding of epigenetic inheritance—how environmental damage to parents gets passed down to future generations without changing DNA itself. As regulators and companies face pressure over long-term health impacts from chemicals and climate change, the inability to predict and measure these transgenerational effects is becoming a costly blind spot.EN

2023-01-01 · Environment International · , , et al.
4.0

A new study shows that ghrelin, the stomach hormone that triggers appetite, also influences how people weigh financial choices—particularly women, who became more patient with money after receiving the hormone. The finding could reshape understanding of decision-making disorders and open new treatment approaches for impulsive financial behavior and addiction.EN

2023-01-01 · Journal of Clinical Investigation · , , et al.
4.0

Researchers have identified the genetic location of a mutation that makes Norway spruce trees grow with a distinctly narrow, upright form—potentially valuable for dense commercial plantations. The finding could accelerate breeding programs and increase timber yield on limited forestland, a key concern for the forestry industry as demand for wood products grows.EN

2023-01-01 · Tree Genetics & Genomes · , , et al.
3.9

A pilot study found that structured outdoor exercise programs designed for dog-owner pairs significantly increased human physical activity and reduced sedentary time, suggesting a scalable intervention for addressing inactivity in both populations. The finding could shape corporate wellness programs and public health strategies targeting dual human-animal health outcomes.EN

2026-01-01 · PLoS ONE · , , et al.
3.9

A new roundtable discussion identifies priority areas for understanding how autistic people age, a population largely overlooked by the healthcare system. The findings signal opportunities for businesses and policymakers to develop services addressing a demographic shift that will reshape long-term care and disability support markets.EN

2026-01-01 · Autism in adulthood · , , et al.
3.9

Researchers found that an eight-week internet-based therapy program significantly reduced tinnitus severity and associated anxiety and depression in Indian patients. The finding suggests a scalable solution for a condition affecting millions in India where standard treatments remain unavailable—creating potential demand for localized digital health platforms targeting underserved populations.EN

2026-01-01 · INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY · , , et al.
3.9

A large-scale analysis of over 4,700 daily dream reports challenges the popular theory that frightening dreams help regulate emotions. Instead, nightmares were linked to more negative mood the following morning—especially among people with strong coping skills. The finding could reshape how therapists approach nightmare treatment and what consumers expect from sleep interventions.EN

2026-01-01 · , , et al.
3.9

Researchers identified over 5,000 proteins in seminal vesicles that influence sperm function and may suppress immune rejection in the female reproductive tract. The discovery could unlock new fertility treatments and contraceptive strategies worth billions in reproductive health markets.EN

2026-01-01 · Proteomics · , , et al.
3.9

Researchers identified how a single genetic typo in the GABRG2 gene triggers severe early-onset epilepsy, often appearing within weeks of birth. The findings could help doctors recognize the condition faster and guide development of targeted treatments for this rare but devastating form of childhood epilepsy.EN

2026-01-01 · Epilepsia · , , et al.
3.9

A clinical trial found that blocking an inflammatory enzyme called myeloperoxidase may help heart failure patients whose hearts still pump reasonably well. The finding could open a new treatment avenue for a large, underserved patient population and reshape how cardiologists approach this growing condition.EN

2024-01-01 · JOURNAL OF CARDIAC FAILURE · , , et al.
3.9

Researchers quantified how often antibiotic use triggers inflammatory bowel disease, establishing a measurable harm threshold that could reshape prescribing practices. The finding has immediate implications for clinical guidelines, pharmaceutical liability, and the trillion-dollar costs of treating chronic gut disorders.EN

2024-01-01 · GUT ·
3.9

A new review connects stress exposure to psychosis risk through specific brain mechanisms, offering a roadmap for early intervention. The findings could reshape how mental health providers identify at-risk patients and develop preventive treatments—a significant market opportunity for pharma and digital mental health companies.EN

2024-01-01 · CURRENT NEUROPHARMACOLOGY · , , et al.
3.9

A 31-country survey reveals that wealthier European healthcare systems have significantly better access to diagnostic equipment for Robin Sequence, a life-threatening newborn airway disorder. The disparity threatens patient outcomes and signals a broader healthcare equity gap that policymakers and medical device companies should address.EN

2023-01-12 · European Journal of Pediatrics · , , et al.
3.9

A new ethics analysis finds that negative language in clinical documentation can worsen symptoms in patients with medically unexplained conditions—a phenomenon called the nocebo effect. The finding suggests healthcare systems should retrain clinicians on how they document cases, potentially reducing patient harm and improving outcomes without new treatments or costs.EN

2023-01-01 · JOURNAL OF MEDICAL ETHICS · ,
3.9

Researchers identified how immune cells detect pH changes in their environment and use that signal to drive allergic responses. The discovery of the GPR65 receptor's role could enable pharmaceutical companies to develop the first drugs that block allergies at this fundamental level, potentially disrupting a market currently dominated by symptom-managing antihistamines.EN

2023-01-01 · ALLERGY · , ,
3.9

A new clinical review synthesizes the evolution of immunotherapies for melanoma, from early approaches to cutting-edge treatments now transforming survival rates. For pharmaceutical companies, healthcare systems, and policymakers, understanding this therapeutic landscape is critical—melanoma incidence continues rising globally, and immunotherapy adoption directly impacts treatment costs, patient outcomes, and competitive positioning in oncology markets.EN

2023-01-01 · CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY · , , et al.